The 580 DNA methylation profiles were generated using Illumina’s Infinium Human Methylation 450k arrays. The 564 normalized RNA-seq v2 profiles were generated by IlluminaHiSeq. HPV status for 72 HPV+ and 243 HPV− samples was obtained from ref. [60 (link)].
Infinium human methylation 450k array
The Infinium Human Methylation 450K array is a high-throughput DNA methylation profiling platform developed by Illumina. The array allows for the comprehensive analysis of DNA methylation patterns across the human genome, covering over 450,000 CpG sites. The core function of the Infinium Human Methylation 450K array is to provide a comprehensive assessment of the DNA methylation status at a large number of genomic regions in a single experiment.
Lab products found in correlation
22 protocols using infinium human methylation 450k array
TCGA Methylation and Expression Analysis
The 580 DNA methylation profiles were generated using Illumina’s Infinium Human Methylation 450k arrays. The 564 normalized RNA-seq v2 profiles were generated by IlluminaHiSeq. HPV status for 72 HPV+ and 243 HPV− samples was obtained from ref. [60 (link)].
TCGA Genome Data Analysis Pipeline
Genome-wide DNA Methylation Profiling in Biomedical Research
Comprehensive Genomic Analysis of GI Cancers
Genome-wide DNA Methylation Profiling
DNA Methylation Profiling with Infinium Arrays
Epigenome-wide DNA Methylation Analysis of Ischemic Stroke
Methylation-based Breast Cancer Diagnosis
In order to evaluate the methylation status of the hTERT hypermethylated oncologic region (THOR), level 3 methylation data derived from the Illumina Infinium HumanMethylation450K array was assessed in BRCA cohort (normal tissue, n = 98 and primary tumor n = 743). The methylation status of the probe cg11625005 (chr5:1,295,737, GRCh37/hg19 genome assembly), which targets a CpG site within THOR region was analyzed. DNA methylation status is presented as beta-values (β values) ranging from 0 to 1, which corresponds to unmethylated and completely methylated DNA, respectively.
The specificity and sensitivity of methylation levels for breast cancer diagnosis were evaluated by receiver operating characteristic (ROC) curve analysis [35 (link)] with diagnostic validity suggested by an area under the ROC curve (AUC) ≥ 0.8.
hTERT gene expression data was derived from Illumina HiSeq 2000 RNA Sequencing (normal tissue, n = 85 and primary tumor, n = 742). This dataset includes gene-level transcription estimates, as in log2 [x + 1] transformed RNA-Seq by Expectation Maximization (RSEM) normalized count.
DNA Methylation Profiling of Whole Blood
DNA Methylation Profiling Using Illumina 450K Array
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!